CBOE's Beat Streak Masks a Revenue Problem Wall Street Keeps Ignoring

Cboe Global Markets (CBOE) reports first-quarter 2026 earnings before the market opens on May 1, with analysts expecting the derivatives and securities exchange operator to deliver its fifth consecutive quarterly beat. The central question is whether CBOE can sustain the momentum from a strong 2025 that saw consistent earnings surprises and robust growth in index options and proprietary products, or if the 33% year-over-year growth estimate proves too ambitious. With the stock trading near all-time highs and technical indicators flashing maximum bullish strength, the stakes are elevated for this closely-watched financial infrastructure play.

Part 1: Earnings Preview

Cboe Global Markets operates the largest U.S. options exchange and provides cutting-edge trading, clearing, and investment solutions across derivatives and securities markets. The company's revenue streams include transaction and clearing fees from options and futures trading, market data subscriptions, and access fees across its global exchange network.

CBOE reports first-quarter 2026 results on May 1 before the opening bell. Analysts expect earnings of $3.33 per share on revenue estimates that are not disclosed in the available data. The company most recently reported $3.06 per share for the fourth quarter of 2025, beating estimates by 4.44%. The consensus estimate represents 33.20% growth compared to $2.50 per share in the first quarter of 2025, marking one of the most aggressive growth expectations in recent quarters.

Three key themes define this earnings story heading into the release:

Index Options Momentum: Solid growth in index options trading volumes, particularly in VIX futures and SPX options, is expected to drive transaction and clearing fee revenue higher. Analysts anticipate that increased volatility and customer demand for proprietary products will continue to fuel this core business segment, which has been a consistent strength for CBOE.

Data and Access Revenue Expansion: Cboe Data Vantage revenues are projected to benefit from increases in access and capacity fees as well as proprietary market data fees. The company has seen growing customer demand for logical and physical port fees across its Options, North American Equities, and Europe/Asia Pacific segments, creating a high-margin revenue tailwind.

Multi-Listed Options and Clearing Growth: Net transaction and clearing fees are expected to rise on the back of increased multi-listed options average daily volume (ADV) and strong performance in Cboe Clear Europe net settlement volumes. The upside may be partially offset by higher royalty fees tied to licensed product trading volumes, but the overall trajectory remains positive.

Leading analysts have turned increasingly bullish heading into the quarter. Multiple firms have raised their estimates in recent weeks, with the consensus moving from $2.67 three months ago to $3.33 currently—a 24.7% upward revision. Zacks Investment Research predicts an earnings beat based on CBOE's positive Earnings ESP of +3.42% and Strong Buy ranking, noting that the Most Accurate Estimate of $3.38 sits above the consensus. Analysts highlight that continued share buybacks and strong proprietary product performance should support bottom-line growth, while the company's consistent execution and market share gains in derivatives trading reinforce confidence in the outlook.

Part 2: Historical Earnings Performance

CBOE has established a reliable pattern of exceeding analyst expectations, delivering earnings beats in each of the last four quarters. The magnitude of these beats has been consistent and meaningful, ranging from 1.65% to 5.93%, with an average surprise of approximately 4.4%. This track record demonstrates management's ability to guide conservatively and execute effectively across market cycles.

The trend shows steady earnings progression throughout 2025, with reported EPS climbing from $2.50 in Q1 to $3.06 in Q4—a 22.4% sequential increase over the year. Each quarter saw CBOE surpass estimates by at least $0.02 per share, with Q1 and Q3 2025 delivering the strongest beats at 5.93% and 5.53% respectively. The consistency of these beats, combined with the upward trajectory in absolute earnings levels, suggests strong operational momentum and effective cost management as the company scales its trading volumes and data services.

Note: These figures reflect diluted GAAP earnings per share, reported before non-recurring items, and may differ from the non-GAAP figures used by some sources.

Part 2.1: Price Behavior Around Earnings

CBOE typically reports earnings before the market opens, meaning Day 0 represents the first trading session where investors react to results, while Day +1 captures follow-through momentum.

Historical price behavior shows CBOE typically delivers a 2.60% absolute move on earnings day (Day 0), with an average intraday range of 4.69%. The Day +1 follow-through averages 1.35% with a 2.91% range, indicating that the initial reaction tends to be larger than subsequent sessions. The direction has been predominantly positive in recent quarters, with six of the last eight earnings days producing gains. Notably, the most recent report in February 2026 saw a muted Day 0 decline of 0.70% followed by a strong 2.75% rally on Day +1, suggesting investors initially underreacted before recognizing the strength of results. The largest single-day move came in August 2024 with a 4.33% gain, while the most volatile session produced a 6.96% intraday range in May 2025. Investors should anticipate a mid-single-digit percentage move in either direction based on this historical pattern.

Part 2.2: Options Market Expected Move

The options market is pricing in an expected move of 2.26% for this earnings release, which sits below the historical average Day 0 move of 2.60% and well below the average intraday range of 4.69%. This suggests options traders may be underpricing potential volatility, particularly given the elevated 33% year-over-year growth estimate and the stock's recent momentum near all-time highs.

Part 3: What Analysts Are Saying

Wall Street maintains a cautious stance on CBOE with a consensus rating of 3.11 (Hold), though the average price target of $302.50 implies modest upside from current levels around $300. The analyst community is divided, with 4 Strong Buy ratings and 11 Hold ratings, but also 3 Strong Sell recommendations among the 18 analysts covering the stock. The high price target of $352 suggests some analysts see significant upside potential of 17% or more, while the low target of $246 indicates bearish outliers remain concerned about valuation.

Sentiment has deteriorated slightly over the past month, with the average recommendation ticking down from 3.12 to 3.11 and one analyst shifting from Hold to Strong Sell. Despite this modest weakening, the consensus price target has actually improved, rising from the mean estimate as several firms have raised their targets following strong fourth-quarter results and positive 2026 guidance. Recent analyst actions include maintains from Barclays, TD Cowen, Piper Sandler, and UBS in January and February 2026, with most firms keeping Hold ratings while acknowledging the company's solid execution.

The current price of $300.09 trades just below the $302.50 consensus target, implying limited upside of less than 1% based on the average analyst view. However, the wide range between the $246 low and $352 high targets—a spread of $106 or 43%—reflects significant disagreement about CBOE's valuation at current levels. Bulls point to the company's consistent earnings beats, growing market share in derivatives, and expanding data revenue streams, while bears likely worry about multiple expansion and the sustainability of elevated trading volumes in a potentially calmer volatility environment.

Part 4: Technical Picture

CBOE enters earnings with exceptional technical momentum, as the Barchart Technical Opinion registers a 100% Buy signal—the maximum bullish reading possible. This represents a dramatic strengthening from just one month ago when the signal stood at 56% Buy, indicating a powerful shift in technical sentiment. The signal has held at 100% Buy for the past week, confirming the strength of the current uptrend.

Timeframe Analysis:

• Short-term (100% Buy): Maximum buy signal indicates powerful near-term momentum heading into the earnings release
• Medium-term (100% Buy): Strong intermediate-term trend confirms this is not just a short-term spike but a sustained advance
• Long-term (100% Buy): Maximum long-term reading suggests the multi-month trend structure remains firmly bullish

Trend Characteristics: The combination of Maximum strength and Strengthening direction creates an exceptionally supportive technical environment for the earnings release, with momentum accelerating across all timeframes.

The moving average structure reinforces this bullish setup, with CBOE trading above its 20-day ($299.88), 50-day ($293.32), 100-day ($277.97), and 200-day ($261.11) moving averages. The stock sits slightly below its 5-day ($302.32) and 10-day ($301.27) averages, suggesting a minor near-term consolidation after a strong run, but the overall trend remains intact with all major moving averages in proper bullish alignment.

The stock's position near $300 represents a psychologically significant level, with the 20-day moving average at $299.88 providing immediate support. The 50-day average at $293.32 offers a secondary support zone roughly 2.3% below current levels, which aligns closely with the options market's expected move. With all major moving averages sloping upward and the stock maintaining a position well above its 200-day average, the technical setup is decidedly supportive heading into earnings. The only cautionary note is the slight pullback from the 5-day and 10-day averages, which could indicate some profit-taking or position squaring ahead of the announcement. However, the overwhelmingly bullish technical indicators and strengthening momentum suggest CBOE is well-positioned to extend gains if results meet or exceed the elevated expectations.